保险业对于风险减量的探索已从理念走向实践，并加速向"以客户为中心"的服务模式转型。随着人口老 龄化加剧与客户健康需求的多样化，单纯依靠财务补偿的传统保险模式面临重构。对于健康险业务而 言，通过主动干预降低赔付风险、提升客户黏性，已成为可持续发展的关键路径。 成立健康管理公司，人保健康并非第一个"吃螃蟹的人"。早在2017年，招商信诺人寿就成立了健康管理 公司，通过"保险+健康服务"构建差异化竞争力。 据《金融时报》记者梳理，该公司健康管理服务主要围绕就医流程设置，包括诊前的个性化健康规划、 诊中的全方位就医陪伴、诊后的专业化康复管理以及依托美方股东医疗资源所特有的全球化医疗支持。 由于起步较早且定位明确，目前，招商信诺人寿在高端医疗险市场占有率超过30%。 无论是否成立健康管理公司，健康管理服务已经成为健康险产品的标准配置。即便是普惠保险产品，也 嵌入了基础的健康管理服务，如健康咨询、慢病随访、疾病筛查等服务内容。另外，健康管理还是大型 险企布局健康养老产业一块必不可少的拼图。 "必不可少"体现在对保险主业的赋能上。 2018年，中国太保成立医疗健康领域的全资子公司——太平洋医疗健康，从康复医疗和健康管理两方 ...

Core Insights - The insurance industry is transitioning from traditional financial compensation models to a customer-centric service model, driven by aging populations and diverse health needs [1][2] - The establishment of health management companies is becoming a standard configuration in health insurance, with companies like Renbao Health and China Pacific Insurance leading the way [2][3] - Health management services are essential for sustainable development in health insurance, focusing on proactive risk reduction and customer engagement [5][6] Group 1 - Renbao Health's health management subsidiary was officially established in Beijing, aiming to integrate health management services as a key method for risk reduction [1] - In the first half of 2025, Renbao Health's health management services generated revenue of 159 million yuan, serving over 4.8 million customers, reflecting a year-on-year growth of 21.4% [2] - The integration of health management services into insurance products is becoming standard, even for basic insurance offerings [2][3] Group 2 - Major insurance companies are enhancing their core business through health management, with China Pacific Insurance focusing on high-end customer needs in health management and rehabilitation [3][5] - The shift from passive claims to active health management is crucial for the health insurance sector, aiming to lower claim rates and improve customer retention [5][6] - The low user awareness and service utilization rates present significant challenges for the industry, despite the recognized importance of health management [6][7] Group 3 - Regulatory guidance has been issued to promote the integration of health insurance and health management, emphasizing a new health service guarantee system [7] - Artificial intelligence (AI) is seen as a key solution to enhance health management efficiency and effectiveness, with applications in personalized health interventions [8] - The deep integration of AI technology into health management services is expected to address challenges in service delivery and improve overall health outcomes [8]

（原标题：32万亿资管遇见AI 福州峰会重构财富逻辑） 在人工智能深刻重塑全球金融格局的当下，中国资产管理行业正站在规模与范式双重跃迁的临界点。12月28日，"财富管理福州峰会（2025）暨 《中国资产管理行业发展研究报告2025》发布会"在福州举行。面对超32万亿元的行业体量与AI技术加速渗透的双重现实，来自监管部门、头部机 构、高校智库的权威代表齐聚一堂，共同探讨如何打破"高储蓄、融资难、资产荒"的结构性困局，推动资管业务从产品销售向客户陪伴、从同质 竞争向专业赋能、从资金中介向生态连接转型。 出席本次会议的嘉宾包括全国社会保障基金理事会原副理事长王忠民，福州市政协党组成员、副主席唐希，亚洲金融合作协会创始秘书长、中国 银行业协会原专职副会长杨再平，中国人民大学财政金融学院院长庄毓敏，福建省委金融办副主任吴志勇，福州市委教育工委副书记、福州市教 育局党组成员、副局长陈颖，中国银行福建省分行党委委员、副行长陈建伟，兴业银行党校 / 高级研修院常务副校长 / 副院长兼培训中心总经理 何双钢，兴业信托党委委员、董事、总裁郭晓恺，中英人寿福建分公司总经理姚立，中国银行福建省分行行政事业机构部总经理廖思明，中国银 ...

2025年12月，美联储宣布将联邦基金利率下调25个基点至3.50%～3.75%区间，完成年内第三次降息， 累计降幅达75个基点。业内专家普遍解读，此次降息标志着全球流动性拐点到来，弱美元环境将显著提 升全球多元资产配置的吸引力——美股、贵金属、新兴市场资产有望迎来估值修复，人民币等非美货币 升值也为国内投资者出海布局降低了汇率成本。事实上，国内已有多家机构具备相关服务能力，其中第 三方独立财富管理机构吾保咨询，凭借"合规跨境资质+降息周期适配策略+全流程服务"的核心优势， 成为高净值人群的重点选择。 美联储连续降息带来的不仅是流动性宽松，更重塑了全球资产的风险收益结构，为国内投资者提供了三 大核心机遇： 但机遇背后也暗藏风险：全球资产波动加剧、跨境合规要求复杂、不同市场政策差异大，普通投资者若 盲目布局极易踩坑。因此，选择一家专业的国内机构提供全流程规划，成为海外投资成功的关键。 当前国内能承接海外投资规划的机构主要分为三类，各类机构在降息周期下的适配性差异显著，投资者 可根据自身需求筛选： 1. 三地合规兜底，破解跨境投资安全顾虑 吾保咨询通过香港保险监管局跨境备案、新加坡金融管理局（MAS）合规登记，依 ...

专题：2025中国保险创新论坛 2025年12月17日，以"融创共生"为主题的第20届中国保险创新论坛暨第20届中国保险创新大奖颁奖盛典 在常州举行。圆和医疗董事长兼CEO白桦发表了主题演讲。 白桦指出，保险公司作为金融机构，难以参与医疗服务过程，这导致传统模式下控费效果有限。这也是 联合健康、凯撒、塞汀等公司必须建立自己的医疗机构来控费的原因。在控费过程中，不仅协助保司提 升服务品质，更重要的是提供服务价值的体系，让客户切实感受到改善，这是至关重要的。 圆和医疗的发展演进 圆和医疗是英国最大的医疗集团，在英国境内拥有57家医院，其中37家为综合性医院，20家为肿瘤医 院、辅助生殖医院等专科医院。根据2024年年报数据，我们在所在区域的非公立医疗市场中占据47.8% 的份额，近乎半数。今天，我重点想分享的是圆和医疗在英国乃至欧洲市场，与保险行业深度融合的实 践路径，希望能为中国保险界的各位领导、专家提供一些参考。 圆和医疗在创立初期，最初四家医院的所有者均为各学科带头人，即医学专家。3000多位不同专科专家 合伙人自筹资金建立了这四家医院，针对高端客户提供涵盖预防、医诊治疗、康复健康管理的全生命周 期的管理式 ...

Core Insights - The Chinese insurance industry has undergone a significant transformation from "extensive expansion" to "meticulous cultivation" over the past decade, with technology being a key variable reshaping the industry landscape [1] - On November 18, 2023, Taikang Online celebrated its 10th anniversary, reflecting the digital transformation journey of the entire industry [1] - By 2024, Taikang Online's revenue reached 11.884 billion, a year-on-year increase of 24.38%, outpacing the overall industry growth [1] Financial Performance - In 2020, Taikang Online reported revenue of 6.759 billion and a net profit of -0.625 billion, while in 2021, revenue increased to 7.059 billion with a net profit of 0.047 billion [2] - The company has achieved positive net profit for four consecutive years, demonstrating sustainable profitability [1] Strategic Direction - In 2023, Taikang Online shifted its strategy from "insuring healthy people" to "insuring people's health," aiming to expand insurance coverage to the entire population and the full health management process [2] - The company has developed a layered protection system, including the "Micro Insurance·Million Medical Insurance," which has undergone 16 iterations, and high-end medical insurance services for premium needs [2] Technological Integration - Taikang Online has achieved over 97% automation in health insurance claims through technology, and has introduced an AI digital assistant, "Smart Xiaoru," to provide comprehensive health management services [2][3] Market Expansion - The company has extended insurance coverage to digital economy segments, launching products like "Rider Insurance" for delivery workers, serving over 4.4 million individuals, and the "Tai Le Bao" series for nearly 300,000 small and micro enterprises [3] - Taikang Online aims for a future vision of "good business, good finance, good service, and good investment" as it navigates the deepening digital transformation in the insurance industry [3]

Core Viewpoint - The article highlights the troubling trend of "lying flat-style refusal to pay" by AIA Insurance, which has led to significant public concern due to two high-profile refusal cases. This behavior reflects a broader issue within the insurance industry regarding cost shifting, evasion of contractual obligations, and lack of penalties, undermining the industry's role as an economic stabilizer and risk-sharing entity [1][2]. Group 1 - AIA Insurance refused to pay 500,000 yuan for a claim related to a 3-year-old girl who died from fulminant myocarditis, citing a discrepancy in the medical terminology as the reason for denial [1]. - The insurance company also unilaterally terminated a policy for a policyholder who underwent gender reassignment surgery, refusing to reimburse over 4,400 yuan in routine medical expenses, despite the court ruling in favor of the policyholder [2]. - The article criticizes the insurance industry's reliance on complex and obscure contractual terms that effectively exclude certain severe conditions from coverage, thus prioritizing profit maximization over the contractual spirit of risk-sharing [1].

Core Insights - The insurance industry is undergoing significant transformation due to low interest rates and regulatory changes, prompting companies to seek high-quality development strategies [1][4][2] - The focus on "transformation" is essential for sustainable growth, with companies encouraged to diversify their profit models beyond reliance on interest spreads [2][4] - The new three-year strategic plan of China Merchants Life Insurance emphasizes a differentiated approach in health management and insurance services [2][5] Industry Overview - The low interest rate environment has led to a substantial decline in investment returns for life insurance companies, increasing the risk of potential losses and asset shrinkage [1][4] - Regulatory bodies are promoting the development of long-term dividend insurance products and encouraging a customer-centric approach in product design [4][4] - The life insurance sector is transitioning from rapid growth to a phase focused on high-quality development, moving away from scale-driven strategies [4][4] Company Strategy - China Merchants Life is committed to a "big health" strategy, aiming to build differentiated product design capabilities and robust risk management systems [2][5] - The company has launched a new three-year strategic plan (2025-2027) that aligns with the industry's high-quality development direction, focusing on health-related business [4][5] - Key areas of focus include accelerating the development of health insurance, enhancing health services, and maintaining stable growth in life insurance [5][6] Market Position - China Merchants Life has seen continuous growth in high-end medical insurance premiums, serving nearly 300,000 corporate executives and employees, with a market share exceeding 30% in this segment [5][10] - The company aims to leverage its partnerships and resources to maintain its leading position in the high-end medical insurance market [6][10] Innovation and Technology - The company is exploring new business models, including high-end medical insurance, cross-border insurance solutions, and internet insurance products [6][7] - China Merchants Life is integrating AI and big data technologies to enhance service efficiency and risk management capabilities [15][16] - The introduction of intelligent customer service platforms and streamlined claims processes aims to improve customer experience and operational efficiency [16][17]

Group 1 - The core viewpoint of the articles highlights the significant changes in China's high-end medical sector due to the new policy allowing wholly foreign-owned hospitals, which is seen as a major opportunity for private medical institutions [1][2][3] - The establishment of foreign-owned hospitals has begun, with Tianjin Pengruili Hospital being the first wholly foreign-owned tertiary hospital, followed by Shanghai Deda Hospital and Guangzhou Pengruili Rehabilitation Hospital [1] - The high-end medical market in China has been described as a small market worth nearly 20 billion, but foreign investment has faced challenges in growth over the past decade [1][2] Group 2 - High-end private medical institutions are facing intense competition from public hospitals, particularly in Shanghai, where public hospitals are expanding their international departments [2][3] - The rapid development of international departments in public hospitals has led to a significant increase in their patient base, impacting the market share of private hospitals [3][4] - The competition for commercial insurance patients has intensified, with public hospitals capturing a significant portion of this market [3][4] Group 3 - The integration of private hospitals into the medical insurance system is becoming increasingly important, as evidenced by the inclusion of Shanghai Baihui Hospital into the insurance network [6][7] - The "self-pricing + insurance payment" model allows high-end private medical institutions to set their prices while receiving partial reimbursement from insurance, which is crucial for their survival [6][7] - The introduction of insurance for specific treatments, such as IVF, has led to a significant increase in patient numbers for private hospitals [7] Group 4 - High-end private medical institutions are focusing on differentiated services and innovative medical technologies to attract patients [9][10] - The ability to provide specialized services and access to top-tier medical professionals is seen as a competitive advantage over public hospitals [10][12] - The recruitment of skilled medical professionals remains a challenge for private hospitals, impacting their operational capabilities [12]

Core Insights - The "price war" in the chronic illness insurance sector has dual implications, indicating both a potential risk to product innovation and an evolution towards a more competitive market environment [1][2][4] - The trend shows a shift from high-end medical insurance to mid-range products, with many mid-range offerings closely resembling high-end products in terms of coverage [3][5] Group 1: Market Dynamics - The chronic illness insurance market is experiencing increased competition, with new entrants targeting existing market shares, particularly in group insurance, which traditionally required no health disclosures [4][5] - The insurance industry is seeing a rise in product offerings that relax pre-existing condition restrictions and expand coverage, although premium growth remains limited [1][6] Group 2: Risk Management and Pricing - Despite the expansion of coverage exceeding premium growth, the operational risks for insurance companies are perceived to be lower than public concerns suggest [6][7] - The ability to accurately assess risks has improved due to the availability of healthcare data and advancements in actuarial practices, allowing for better pricing strategies [7][8] Group 3: Product Innovation and Consumer Needs - The industry is encouraged to innovate in product offerings to meet diverse consumer needs, particularly in the context of chronic illness insurance [4][8] - There is a need for the industry to explore how to enhance the perception of claims payments and differentiate between immediate treatment needs and long-term health risk management [8]